Lung cancer (LC) is a highly prevalent malignancy and a leading cause of cancer mortality worldwide, often diagnosed at advanced stages. Malnutrition and metabolic alterations are frequent and are linked to poorer quality of life, lower treatment tolerance, and worse prognosis. Precision nutrition, integrating nutritional, metabolic, and nutrigenomic approaches, may help reduce sarcopenia, treatment toxicity, and improve quality of life.
Moyano et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: